Axiom Space’s Ax-4 mission, launched on a SpaceX Dragon spacecraft, will carry a historic international crew to the International Space Station (ISS) next Tuesday, June 10, from NASA’s Kennedy Space Center in Florida.
SpaceX’s Dragon capsule was recently photographed preparing for the Ax-4 launch. The Dragon will dock at the ISS on June 11 at approximately 12:30 p.m. ET for a 14-day mission focused on groundbreaking microgravity research.
The Ax-4 crew will be led by Commander Peggy Whitson from the United States. It includes Pilot Shubhanshu Shukla from India and mission specialists Sławosz Uznański-Wiśniewski from Poland and the European Space Agency and Tibor Kapu from Hungary. This mission marks a historic return to human spaceflight for India, Poland, and Hungary as each nation sends its first government-sponsored astronauts in over 40 years.
“With a culturally diverse crew, we are not only advancing scientific knowledge but also fostering international collaboration. Our previous missions set the stage, and with Ax-4, we ascend even higher, bringing more nations to low-Earth orbit and expanding humanity’s reach among the stars,” Whitson noted.
The Ax-4 mission’s research portfolio will be Axiom’s most extensive. It includes 60 scientific studies from 31 countries, including the U.S., India, Poland, Hungary, Saudi Arabia, Brazil, Nigeria, the UAE, and Europe. These studies will advance knowledge in human research, Earth observation, life, and biological and material sciences. Key investigations include supporting astronauts with insulin-dependent diabetes, examining microgravity’s impact on the brain, and studying cancer growth, particularly triple-negative breast cancer. Additional research will explore blood stem cells, joint health, blood flow, and astronaut readiness using wearable devices, iPhone software, and AWS Snowcone analytics.
Axiom Space’s partnerships with research organizations and academic institutions aim to deepen understanding of spaceflight’s effects on the human body, with potential applications for Earth-based healthcare. The Ax-4 mission underscores Axiom’s role in redefining access to low-Earth orbit, fostering global collaboration, and advancing microgravity research. As SpaceX’s Dragon enables this historic mission, it reinforces the company’s pivotal role in commercial spaceflight and scientific discovery.
